High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings
一线高效抗逆转录病毒疗法失败后,临床显著突变发生率高:对资源匮乏地区二线治疗方案的启示
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1086/600044
Kumarasamy, N; Madhavan, Vidya; Venkatesh, Kartik K; Saravanan, S; Kantor, Rami; Balakrishnan, P; Devaleenal, Bella; Poongulali, S; Yepthomi, Tokugha; Solomon, Suniti; Mayer, Kenneth H; Benson, Constance; Schooley, Robert